Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT02460458
Eligibility Criteria:
Inclusion Criteria:
* Male and female of any age, including infants, children, adolescent and adults
* Informed Consent obtained (parents should sign for patients \< 18 y.o.)
* Previous Diagnosis of VWD3 (VWF Antigen: undetectable or \<5 U/dL)
* Detailed information on inherited pattern, history of bleeding, previous exposure to blood products
* Availability of plasma and DNA samples
Exclusion Criteria:
• VWD3 patients who may not be available for follow-up
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02460458
Study Brief:
Protocol Section:
NCT02460458